Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Congying Zheng, Chengliang Mao, Kai Tang & Hang Shu. (2023) VSIG4 Silencing Inhibits Glioblastoma Growth by Regulating the JAK2/STAT3 Pathway. Neuropsychiatric Disease and Treatment 19, pages 1397-1408.
Read now
Read now
Liping Li, Chao Qi, Yuanyuan Liu, Youliang Shen, Xia Zhao, Han Qin, Yi Zhang & Tengbo Yu. (2021) MicroRNA miR-27b-3p regulate microglial inflammation response and cell apoptosis by inhibiting A20 (TNF-α-induced protein 3). Bioengineered 12:2, pages 9902-9913.
Read now
Read now
Articles from other publishers (4)
Bei Liu, Li Cheng, Honghao Gao, Jiale Zhang, Yanxin Dong, Wenda Gao, Shunzong Yuan, Taiqian Gong & Wenrong Huang. (2023) The biology of VSIG4: Implications for the treatment of immune-mediated inflammatory diseases and cancer. Cancer Letters 553, pages 215996.
Crossref
Crossref
Hui-zhong Jiang, Bing Yang, Ya-li Jiang, Xun Liu, Da-lin Chen, Feng-xi Long, Zhu Yang & Dong-xin Tang. (2022) Development and validation of prognostic models for colon adenocarcinoma based on combined immune-and metabolism-related genes. Frontiers in Oncology 12.
Crossref
Crossref
Yanan Wang, Jie Ding, Hejian Song, Yanling Teng & Xiaoling Fang. (2022) VSIG4 regulates macrophages polarization and alleviates inflammation through activating PI3K/AKT and inhibiting TLR4/NF-κB pathway in myocardial ischemia-reperfusion injury rats. Physiology International.
Crossref
Crossref
Wei-Feng Zong, Cui Liu, Yi Zhang, Suo-Jun Zhang, Wen-Sheng Qu & Xiang Luo. (2022) Identification of a Signature for Predicting Prognosis and Immunotherapy Response in Patients with Glioma. Journal of Oncology 2022, pages 1-13.
Crossref
Crossref